Cardinal Health financials
$220.29+0.03%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jun 30 | FY25 Jun 30 | FY24 Jun 30 | FY23 Jun 30 | FY22 Jun 30 | FY21 Jun 30 | FY20 Jun 30 | FY19 Jun 30 | FY18 Jun 30 | FY17 Jun 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B |
| Gross profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B |
| Gross margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% |
| Operating income | $2.79B | $2.29B | $1.88B | $752.0M | $1.45B | $551.0M | -$4.09B | $1.57B | $1.54B | $2.14B |
| Net income | $1.71B | $1.56B | $852.0M | $330.0M | -$938.0M | $611.0M | -$3.70B | $1.36B | $256.0M | $1.29B |
| Net margin | 0.7% | 0.7% | 0.4% | 0.2% | −0.5% | 0.4% | −2.4% | 0.9% | 0.2% | 1.0% |
| Diluted EPS | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 |
| EBITDA | $3.84B | $2.99B | $2.84B | $2.77B | $2.34B | $2.58B | $2.69B | $2.73B | $2.91B | $2.96B |
| Operating cash flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.19B |
| Free cash flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.79B | $2.03B | $1.58B | $2.39B | $2.39B | $802.0M |
| Diluted shares | 237.0M | 242.0M | 247.0M | 262.0M | 279.0M | 294.0M | 293.0M | 301.0M | 315.0M | 320.0M |
Balance sheet
| Period end | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $8.89B | $8.53B | $4.66B | $4.70B | $5.32B | $6.24B |
| Total assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B |
| Total liabilities | $60.02B | $55.76B | $48.33B | $46.31B | $44.58B | $42.66B |
| Shareholders' equity | -$2.72B | -$2.63B | -$3.21B | -$2.96B | -$706.0M | $1.79B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology